Gross Profit Increased 23.5% from the
Previous Year to $7.7
million
Gross Margins Increased to 18.5%, up from
15.0% the Previous Year
Revenue Increased 0.3% Year-Over-Year to
$41.8 Million
LOS
ANGELES, Feb. 10, 2025 /PRNewswire/
-- Ispire Technology Inc. (NASDAQ:
ISPR) ("Ispire," the "Company," "we," "us," or "our"), an
innovator in vaping technology and precision dosing, today reported
results for the fiscal second quarter 2025, which ended on
December 31, 2024.
Fiscal Second Quarter 2025 Financial Results
- Revenue of $41.8 million,
compared to $41.7 million for the
fiscal second quarter of 2024.
- Gross profit of $7.7
million, an increase of 23.5% compared to $6.3 million in the fiscal second quarter of
2024.
- Gross margin of 18.5%, an increase of 23% compared to
15.0% second quarter of fiscal 2024.
- Total operating expenses of $15.1
million, an increase of 48.0% as compared to $10.2 million for second quarter of fiscal
2024.
- Net loss of ($8.0)
million, compared to net loss of ($4.0) million in the second quarter of fiscal
2024.
"Despite challenging macroeconomic conditions, we had strong
results for the quarter given the strategic advances we made in
becoming a leading global innovative vaping technology and
precision dosing solutions company," said Michael Wang, Co-Chief Executive Officer of
Ispire. "This is particularly evident as we further expanded into
international markets. Our BrkFst brand recently launched in
Africa, marking our first
international nicotine license arrangement and product launch. The
BrkFst brand has seen early success as we have quickly established
a presence in over 500 retail locations across South Africa and Nigeria, including major chains like Pick n
Pay and Forecourts. We've implemented a sweeping market activation
strategy with brand ambassadors conducting daily events in major
metropolitan areas, which has been instrumental in building strong
relationships with both retailers and consumers. We now plan to
accelerate our expansion strategy to reach more than 2,000 stores
in the next six months through additional strategic
partnerships."
"Furthermore, our IKE Tech joint venture's component PMTA
strategy represents a groundbreaking opportunity. We've completed a
successful pre-PMTA meeting with the FDA, who indicated they would
accept our component PMTA submission and consider our priority
review. The legal U.S. market for electronic nicotine delivery
systems is approximately $11 billion,
with an additional $7 billion
potential in alternative markets. This is a significant opportunity
for our potentially industry changing blockchain-based age
verification technology which could help prevent youth access," Mr.
Wang concluded.
Jim McCormick, Chief Financial
Officer of Ispire, added, "Our financial performance this quarter
demonstrates our ability to execute on our strategic priorities for
growth and financial management. The authorization by the Board of
up to a $10 million stock repurchase
program underscores our confidence in Ispire's long-term potential
and our commitment to creating value for shareholders. In
Malaysia, we've made significant
regulatory progress, obtaining critical nicotine import and export
licenses and preparing for our manufacturer's license, which we
expect will enable us to scale our operations to 70 production
lines in our new facility. Also, subsequent to quarter end, the
Company moved certain daily roles and functions to our Malaysian
operations to help further streamline our overall business and to
reduce operating expenses by an anticipated $8 million annually. This balanced approach
allows us to simultaneously invest in our growth strategies and
return value to our shareholders, which we believe positions us for
continued success in the evolving global nicotine product
market."
Financial Results for the Fiscal Second Quarter Ended
December 31, 2024
Ispire reported revenue of $41.8
million for the fiscal second quarter ended December 31, 2024, compared to $41.7 million for the prior comparable period, an
increase of $0.1 million. The
growth in revenue is largely due to the increase in
contribution of sales from expansion overseas.
Gross profit for the second quarter of fiscal 2025, was
$7.7 million compared to $6.3 million in the year-ago period. Gross margin
increased to 18.5% from 15.0% in the second quarter of fiscal 2024.
The increase in gross profit and gross margin was primarily due to
changes in product mix with more higher margin products being sold
during the three months ended December 31,
2024.
Total operating expenses for the second fiscal quarter of 2025
were $15.1 million, compared to
$10.2 million for second fiscal
quarter of 2024. The increase in operating expenses was primarily
due to increased expenses associated with our increased revenue
generation, continued investment in Malaysia, and increased expenses related to
our product development function.
Net loss was $8.0 million or
($0.14) per share for the fiscal
second quarter of 2025, versus a net loss of $4.0 million, or ($0.07) per share for the fiscal second quarter
of 2024.
At December 31, 2024, Ispire
had a cash position of $34.4
million, as well as working capital of $6.1 million.
Conference Call
The Company will conduct a conference call at 8:00am Eastern
Time on Monday, February 10,
2025, to discuss the results. Ispire management will host
the conference call, followed by a question-and-answer period.
Please call the conference call dial-in 5-10 minutes prior to
the start time and ask for the "Ispire Technology Call." An
operator will register your name and organization.
- Date: Monday, February 10, 2025
- Time: 8:00am ET
- Dial-In Numbers: United States 877-451-6152 or
International +1 201-389-0879
This conference call will be broadcast live on the Internet and
can be accessed by all interested parties at
https://viavid.webcasts.com/starthere.jsp?ei=1705094&tp_key=6946006674.
Please access the link at least fifteen minutes prior to the
start of the call to register, download, and install any necessary
audio software.
A playback will be available from 11:00 am
ET on February 10, 2025, through February 24, 2025.
To listen, please dial +1 844-512-2921 or +1 412-317-6671. Use the
passcode 13751256 to access the replay.
About Ispire Technology Inc.
Ispire is engaged in the research and development, design,
commercialization, sales, marketing, and distribution of branded
e-cigarettes and cannabis vaping products. The Company's operating
subsidiaries own or license more than 200 patents received or filed
globally. Ispire's tobacco products are marketed under the Aspire
brand name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global
distribution network. The Company's cannabis products are marketed
under the Ispire brand name primarily on an original design
manufacturer (ODM) basis to other cannabis vapor companies. Ispire
sells its cannabis vaping hardware only in the U.S., and it
recently commenced its marketing activities in Canada
and Europe. For more information,
visit www.ispiretechnology.com or follow Ispire on
Instagram, LinkedIn, Twitter and YouTube. Any
information contained on, or that can be accessed through, the
Company's website, any other website or any social media, is not a
part of this press release.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended ("Securities Act") as well as Section 21E of the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995, as amended, that are intended to be
covered by the safe harbor created by those sections.
Forward-looking statements, which are based on certain assumptions
and describe the Company's future plans, strategies and
expectations, can generally be identified by the use of
forward-looking terms such as "believe," "expect," "may," "will,"
"should," "would," "could," "seek," "intend," "plan," "goal,"
"project," "estimate," "anticipate," "strategy," "future," "likely"
or other comparable terms, although not all forward-looking
statements contain these identifying words. All statements other
than statements of historical facts included in this press release
regarding the Company's strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking
statements. Important factors that could cause the Company's actual
results and financial condition to differ materially from those
indicated in the forward-looking statements. Such forward-looking
statements include, but are not limited to, risks and uncertainties
including those regarding: whether the Company may be successful in
re-entering the U.S. ENDS market; the approval or rejection of
any PMTA submitted by the Company; whether the Company will be
successful in its plans to further expand into the African market;
whether the Company's joint venture with Touch Point Worldwide Inc.
d/b/a/ Berify and Chemular Inc. (the "Joint Venture") may be
successful in achieving its goals as currently contemplated, with
different terms, or at all; the Joint Venture's ability to innovate
in the e-cigarette technology space or develop age gating or age
verification technologies for nicotine vaping devices; the
Company's ability to collect its accounts receivable in a timely
manner; the Company's business strategies; the ability of the
Company to market to the Ispire ONE™; Ispire ONE™'s success in
meeting its goals; the ability of its customers to derive the
anticipated benefits of the Ispire ONE™ and the success of its
products on the markets; the Ispire ONE™ proving to be safe; and
the risk and uncertainties described in "Risk Factors,"
"Management's Discussion and Analysis of Financial Condition and
Results of Operations," "Cautionary Note on Forward-Looking
Statements" and the additional risk described in Ispire's Annual
Report on Form 10-K for the year ended June 30, 2024 and any
subsequent filings which Ispire makes with the SEC. You should not
rely upon forward-looking statements as predictions of future
events. The forward-looking statements made in this press release
relate only to events or information as of the date on which the
statements are made in this press release. We undertake no
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
after the date on which the statements are made or to reflect the
occurrence of unanticipated events except as required by applicable
law. You should read this press release with the understanding that
our actual future results may be materially different from what we
expect.
ISPIRE TECHNOLOGY
INC.
|
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(In $USD, except
share and per share data)
|
|
|
|
December 31,
2024
|
|
|
June 30,
2024
|
|
Assets
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
|
|
$
|
34,372,851
|
|
|
$
|
35,071,294
|
|
Restricted
cash
|
|
|
22,535
|
|
|
|
-
|
|
Accounts receivable,
net
|
|
|
67,700,463
|
|
|
|
59,734,765
|
|
Inventories,
net
|
|
|
7,900,110
|
|
|
|
6,365,394
|
|
Prepaid expenses and
other current assets
|
|
|
2,324,245
|
|
|
|
1,400,152
|
|
Total current
assets
|
|
|
112,320,204
|
|
|
|
102,571,605
|
|
Non-current
assets:
|
|
|
|
|
|
|
|
|
Property, plant and
equipment, net
|
|
|
2,365,115
|
|
|
|
2,582,457
|
|
Intangible assets,
net
|
|
|
2,120,367
|
|
|
|
1,375,666
|
|
Right-of-use assets –
operating leases
|
|
|
2,949,756
|
|
|
|
3,579,140
|
|
Other
investment
|
|
|
2,000,000
|
|
|
|
2,000,000
|
|
Equity method
investment
|
|
|
10,071,380
|
|
|
|
10,248,048
|
|
Other non-current
assets
|
|
|
215,612
|
|
|
|
284,050
|
|
Total non-current
assets
|
|
|
19,722,230
|
|
|
|
20,069,361
|
|
Total assets
|
|
$
|
132,042,434
|
|
|
$
|
122,640,966
|
|
Liabilities and
stockholders' equity
|
|
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
5,156,302
|
|
|
$
|
3,779,723
|
|
Accounts payable –
related party
|
|
|
86,375,645
|
|
|
|
67,046,472
|
|
Contract
liabilities
|
|
|
1,882,743
|
|
|
|
2,218,166
|
|
Accrued liabilities and
other payables
|
|
|
11,576,021
|
|
|
|
11,738,339
|
|
Operating lease
liabilities – current portion
|
|
|
1,245,061
|
|
|
|
1,207,832
|
|
Total current
liabilities
|
|
|
106,235,772
|
|
|
|
85,990,532
|
|
|
|
|
|
|
|
|
|
|
Non-current
liabilities:
|
|
|
|
|
|
|
|
|
Operating lease
liabilities – net of current portion
|
|
|
1,572,574
|
|
|
|
2,194,094
|
|
Total
liabilities
|
|
|
107,808,346
|
|
|
|
88,184,626
|
|
|
|
|
|
|
|
|
|
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Common stock, par value
$0.0001 per share; 140,000,000 shares authorized;
56,677,982 and 56,470,636 shares issued and outstanding as of
December 31,
2024 and June 30, 2024
|
|
|
5,668
|
|
|
|
5,647
|
|
Preferred stock, par
value $0.0001 per share, 10,000,000 shares authorized, no
shares issued at December 31, 2024 and June 30,
2024
|
|
|
-
|
|
|
|
-
|
|
Additional paid-in
capital
|
|
|
46,670,244
|
|
|
|
43,217,391
|
|
Accumulated
deficit
|
|
|
(22,418,700)
|
|
|
|
(8,825,041)
|
|
Accumulated other
comprehensive (loss) income
|
|
|
(23,124)
|
|
|
|
58,343
|
|
Total stockholders'
equity
|
|
|
24,234,088
|
|
|
|
34,456,340
|
|
Total liabilities and
stockholders' equity
|
|
$
|
132,042,434
|
|
|
$
|
122,640,966
|
|
ISPIRE TECHNOLOGY
INC.
|
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS
|
(In $USD, except
share and per share data)
|
|
|
|
Three Months Ended
December 31,
|
|
|
Six Months Ended
December 31,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
41,827,860
|
|
|
$
|
41,685,561
|
|
|
$
|
81,166,173
|
|
|
$
|
84,550,208
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenue
|
|
|
34,105,289
|
|
|
|
35,432,663
|
|
|
|
65,769,224
|
|
|
|
71,452,462
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
7,722,571
|
|
|
|
6,252,898
|
|
|
|
15,396,949
|
|
|
|
13,097,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
expenses
|
|
|
2,061,664
|
|
|
|
1,394,407
|
|
|
|
5,053,911
|
|
|
|
2,419,626
|
|
General and
administrative expenses
|
|
|
13,020,962
|
|
|
|
8,778,715
|
|
|
|
22,965,962
|
|
|
|
15,476,589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Operating
expenses
|
|
|
15,082,626
|
|
|
|
10,173,122
|
|
|
|
28,019,873
|
|
|
|
17,896,215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from
operations
|
|
|
(7,360,055)
|
|
|
|
(3,920,224)
|
|
|
|
(12,622,924)
|
|
|
|
(4,798,469)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income,
net
|
|
|
59,755
|
|
|
|
203,101
|
|
|
|
59,841
|
|
|
|
275,347
|
|
Exchange gain (loss),
net
|
|
|
(245,173)
|
|
|
|
30,856
|
|
|
|
(127,588)
|
|
|
|
34,517
|
|
Other income (expense),
net
|
|
|
6,861
|
|
|
|
46,535
|
|
|
|
13,796
|
|
|
|
3,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Other income
(expense), net
|
|
|
(178,557)
|
|
|
|
280,492
|
|
|
|
(53,951)
|
|
|
|
313,195
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income
taxes
|
|
|
(7,538,612)
|
|
|
|
(3,639,732)
|
|
|
|
(12,676,875)
|
|
|
|
(4,485,274)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes -
current
|
|
|
(460,031)
|
|
|
|
(352,180)
|
|
|
|
(916,784)
|
|
|
|
(848,225)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(7,998,643)
|
|
|
$
|
(3,991,912)
|
|
|
$
|
(13,593,659)
|
|
|
$
|
(5,333,499)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive
loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency
translation adjustments
|
|
|
73,470
|
|
|
|
114,327
|
|
|
|
(81,467)
|
|
|
|
158,790
|
|
Comprehensive income
(loss)
|
|
$
|
(7,925,173)
|
|
|
$
|
(3,877,585)
|
|
|
$
|
(13,675,126)
|
|
|
$
|
(5,174,709)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per
share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
diluted
|
|
$
|
(0.14)
|
|
|
$
|
(0.07)
|
|
|
$
|
(0.24)
|
|
|
$
|
(0.10)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
diluted
|
|
|
56,658,012
|
|
|
|
54,270,236
|
|
|
|
56,629,666
|
|
|
|
54,258,224
|
|
For more information, kindly contact:
IR Contacts:
Investor Relations
Sherry Zheng
718-213-7386
ir@ispiretechnology.com
KCSA Strategic Communications
Phil Carlson
212-896-1233
ispire@kcsa.com
PR Contact:
Ellen
Mellody
570-209-2947
EMellody@kcsa.com
View original
content:https://www.prnewswire.com/news-releases/ispire-technology-inc-reports-financial-results-for-fiscal-second-quarter-2025-302371600.html
SOURCE Ispire Technology Inc.